Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 256

1.

Psoriasiform Dermatitis After Initiation of Treatment with Dupilumab for Atopic Dermatitis.

Fowler E, Silverberg JI, Fox JD, Yosipovitch G.

Dermatitis. 2019 May/Jun;30(3):234-236. doi: 10.1097/DER.0000000000000481. No abstract available.

PMID:
31094943
2.

Atopic dermatitis is associated with increased hospitalization in United States children.

Hua T, Silverberg JI.

J Am Acad Dermatol. 2019 May 11. pii: S0190-9622(19)30782-0. doi: 10.1016/j.jaad.2019.05.019. [Epub ahead of print] No abstract available.

PMID:
31085271
3.

Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled Analysis.

Eichenfield LF, Bieber T, Beck LA, Simpson EL, Thaçi D, de Bruin-Weller M, Deleuran M, Silverberg JI, Ferrandiz C, Fölster-Holst R, Chen Z, Graham NMH, Pirozzi G, Akinlade B, Yancopoulos GD, Ardeleanu M.

Am J Clin Dermatol. 2019 May 7. doi: 10.1007/s40257-019-00445-7. [Epub ahead of print]

PMID:
31066001
4.

Associations of cutaneous and extra-cutaneous infections with Hidradenitis Suppurativa in US children and adults.

Lee HH, Patel KR, Singam V, Rastogi S, Silverberg JI.

Br J Dermatol. 2019 May 2. doi: 10.1111/bjd.18093. [Epub ahead of print]

PMID:
31049925
5.

Presentation of Psoriasiform Dermatitis After Initiation of Treatment With Dupilumab for Atopic Dermatitis.

Fowler E, Silverberg JI, Fox JD, Yosipovitch G.

Dermatitis. 2019 Apr 29. doi: 10.1097/DER.0000000000000481. [Epub ahead of print] No abstract available.

PMID:
31045938
6.

Comorbidities and the impact of atopic dermatitis.

Silverberg JI.

Ann Allergy Asthma Immunol. 2019 Apr 26. pii: S1081-1206(19)30319-9. doi: 10.1016/j.anai.2019.04.020. [Epub ahead of print] Review. No abstract available.

PMID:
31034875
7.

Predictors of hospital readmission in US children and adults with atopic dermatitis.

Cheng BT, Silverberg JI.

Ann Allergy Asthma Immunol. 2019 Apr 24. pii: S1081-1206(19)30315-1. doi: 10.1016/j.anai.2019.04.016. [Epub ahead of print]

PMID:
31028895
8.

Validation and interpretation of short form 12 and comparison with dermatology life quality index in atopic dermatitis in adults.

Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Ong PY, Chiesa Fuxench ZC, Simpson EL.

J Invest Dermatol. 2019 Apr 19. pii: S0022-202X(19)31488-5. doi: 10.1016/j.jid.2019.03.1152. [Epub ahead of print]

PMID:
31009616
9.

A successful case of dupilumab treatment for severe uremic pruritus.

Silverberg JI, Brieva J.

JAAD Case Rep. 2019 Apr 3;5(4):339-341. doi: 10.1016/j.jdcr.2019.01.024. eCollection 2019 Apr. No abstract available.

10.

Validation of five patient-reported outcomes for atopic dermatitis severity in adults.

Silverberg JI, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Ong PY, Fuxench ZC, Simpson EL.

Br J Dermatol. 2019 Apr 10. doi: 10.1111/bjd.18002. [Epub ahead of print]

PMID:
30972740
11.

Association of dermatomyositis with systemic and opportunistic infections in the United States.

Ren Z, Laumann AE, Silverberg JI.

Arch Dermatol Res. 2019 Apr 6. doi: 10.1007/s00403-019-01913-0. [Epub ahead of print]

PMID:
30955081
12.

New and emerging therapies for paediatric atopic dermatitis.

Vakharia PP, Silverberg JI.

Lancet Child Adolesc Health. 2019 May;3(5):343-353. doi: 10.1016/S2352-4642(19)30030-6. Epub 2019 Mar 20. Review.

PMID:
30904349
13.

Variable impact of dupilumab on patch testing results and allergic contact dermatitis in adults with atopic dermatitis.

Stout M, Silverberg JI.

J Am Acad Dermatol. 2019 Mar 15. pii: S0190-9622(19)30434-7. doi: 10.1016/j.jaad.2019.03.020. [Epub ahead of print]

PMID:
30885752
14.

Outpatient utilization patterns for atopic dermatitis in the United States.

Singh P, Silverberg JI.

J Am Acad Dermatol. 2019 Mar 15. pii: S0190-9622(19)30435-9. doi: 10.1016/j.jaad.2019.03.021. [Epub ahead of print]

PMID:
30885751
15.

Distribution of atopic dermatitis lesions in United States adults.

Silverberg JI, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Ong PY, Chiesa Fuxench ZC, Simpson EL, Gelfand JM.

J Eur Acad Dermatol Venereol. 2019 Mar 18. doi: 10.1111/jdv.15574. [Epub ahead of print]

PMID:
30883885
16.

Optimization of placebo use in clinical trials with systemic treatments for atopic dermatitis: an International Eczema Council survey-based position statement.

Leshem YA, Bissonnette R, Paul C, Silverberg JI, Irvine AD, Paller AS, Cork MJ, Guttman-Yassky E.

J Eur Acad Dermatol Venereol. 2019 May;33(5):807-815. doi: 10.1111/jdv.15480. Epub 2019 Mar 12.

17.

Symptoms and diagnosis of anxiety and depression in atopic dermatitis in U.S. adults.

Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Ong PY, Chiesa Fuxench ZC, Simpson EL.

Br J Dermatol. 2019 Mar 5. doi: 10.1111/bjd.17683. [Epub ahead of print]

PMID:
30838645
18.

Atopic dermatitis: it's not just barrier dysfunction.

Silverberg JI.

Br J Dermatol. 2019 Mar;180(3):447-448. doi: 10.1111/bjd.17499. No abstract available.

PMID:
30821371
19.

Safety equipment: When protection becomes a problem.

Warshaw EM, Schlarbaum JP, Silverberg JI, DeKoven JG, Maibach HI, Sasseville D, Fowler JF Jr, Marks JG Jr, Belsito DV, Reeder MJ, Mathias T, Atwater AR, Taylor JS, Fransway AF, Pratt MD, DeLeo VA, Zirwas MJ, Zug KA.

Contact Dermatitis. 2019 Feb 27. doi: 10.1111/cod.13254. [Epub ahead of print] No abstract available.

PMID:
30809819
20.

Systemic Therapies for Moderate-to-Severe Atopic Dermatitis: Expert Perspectives in Practice

Lebwohl M, Alexis AF, Beck LA, Block JK, Eichenfield LF, Fonacier L, Guttman-Yassky E, Paller AS, Pariser D, Silverberg JI, Boguniewicz M.

J Drugs Dermatol. 2019 Feb 1;18(2):122-129.

PMID:
30794360

Supplemental Content

Loading ...
Support Center